RELISTOR: payments to doctors
Payments that named RELISTOR as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $4.2M
- Providers
- 18,622
- Transactions
- 171,326
- Average per transaction
- $25
The per-transaction average — $25 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 18,622 providers the average total is $226, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | $4,201,269 | 100.0% |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | $17 | 0.0% |